P3.12.48 Efficacy and Safety of Savolitinib in Advanced or Metastatic METex14 NSCLC Patients With or Without Prior Immunotherapy
0Citations signalées, ce qui n’est pas une note de qualité
58Institutions déclarées
1Pays d’affiliation déclarés
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Résumé indisponible. Les résultats de l’étude ne doivent pas être déduits de son seul titre.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- P3.12.48 Efficacy and Safety of Savolitinib in Advanced or Metastatic METex14 NSCLC Patients With or Without Prior Immunotherapy
- Date Crossref
- 01/10/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Shanghai Chest HospitalShandong Tumor HospitalShandong First Medical UniversityHunan Cancer HospitalPeking UniversityPeking University Cancer HospitalTianjin Medical University General HospitalHarbin Medical UniversityThird Affiliated Hospital of Harbin Medical UniversityCentral South UniversityXiangya Hospital Central South UniversityWenzhou Medical UniversityZhejiang Taizhou HospitalHenan Cancer HospitalSichuan Cancer HospitalJiangxi Provincial Cancer HospitalXinjiang Medical UniversityTumor Hospital of Xinjiang Medical UniversityPeople 's Liberation Army 451 HospitalXi'an Medical UniversityZhejiang Cancer HospitalBeijing Chest HospitalNanchang UniversitySecond Affiliated Hospital of Nanchang UniversityFirst Hospital of China Medical UniversitySichuan UniversityWest China Hospital of Sichuan UniversityFirst Affiliated Hospital Zhejiang UniversityAnhui Provincial HospitalHubei Cancer HospitalShanxi Provincial Cancer HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegePeking Union Medical College HospitalNantong Tumor HospitalLiaoning Cancer Hospital & InstituteAffiliated Hospital of Hebei UniversityFirst Affiliated Hospital of Zhengzhou UniversityJilin Province Tumor HospitalTianjin Medical University Cancer Institute and HospitalXuzhou Central HospitalQingdao UniversityAffiliated Hospital of Qingdao UniversityTongji HospitalSoochow UniversityFirst Affiliated Hospital of Soochow UniversityXi'an Chest HospitalShanghai Huali Microelectronics (China)Affiliated Hangzhou First People's Hospital, Westlake University, School of MedicineJiangsu Province HospitalNanjing Medical UniversityNingbo No. 2 HospitalSecond Affiliated Hospital of Zhejiang UniversityHuazhong University of Science and TechnologyWeifang People's HospitalNorthern Jiangsu People's HospitalCancer Hospital of Chinese Academy of Medical SciencesHenan Provincial People's HospitalShangri-la Institute
Une affiliation ne permet pas de déduire la nationalité d’un auteur.
Les sujets associés
Lung Cancer Treatments and MutationsGastric Cancer Management and OutcomesGastrointestinal Tumor Research and Treatment